Biotech · Public company · King Of Prussia, PA, US
Phio Pharmaceuticals Corp.
Ticker PHIO · SEC CIK 0001533040
Track this companyFree. Adds Phio Pharmaceuticals Corp. to your Dealase workspace and tells you when its record changes.
Clinical trials21 recruiting or active
Pipeline programs1From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availableNo recent cash burn filed
Pipeline1
- PH-762Phase 1 · Squamous Cell Carcinoma of the SkinClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials2
- Intratumoral PH-762 for Cutaneous CarcinomaPHASE1 · COMPLETED · started Nov 7, 2023ClinicalTrials.gov NCT06014086 · fetched Nov 12, 2026
- Adoptive Cell Therapy Using Cancer Specific CD8+ Tumor Infiltrating Lymphocytes in Adult Patients With Solid TumorsPHASE1 · ACTIVE_NOT_RECRUITING · started Jun 19, 2023ClinicalTrials.gov NCT05902520 · fetched Nov 12, 2026
SEC filings12
- 10-Q · FORM 10-QSEC EDGAR · filed Nov 5, 2026 · fetched Nov 12, 2026
- 8-K · FORM 8-KSEC EDGAR · filed Nov 5, 2026 · fetched Nov 12, 2026
- 8-K · FORM 8-KSEC EDGAR · filed Oct 13, 2026 · fetched Nov 12, 2026
- 8-K · FORM 8-KSEC EDGAR · filed Sep 28, 2026 · fetched Nov 12, 2026
- 8-K · FORM 8-KSEC EDGAR · filed Sep 14, 2026 · fetched Nov 12, 2026
- 8-K · FORM 8-KSEC EDGAR · filed Aug 6, 2026 · fetched Nov 12, 2026
- 10-Q · FORM 10-QSEC EDGAR · filed Aug 6, 2026 · fetched Nov 12, 2026
- 8-K · FORM 8-KSEC EDGAR · filed Jul 21, 2026 · fetched Nov 12, 2026
- 10-Q · FORM 10-QSEC EDGAR · filed May 7, 2026 · fetched Nov 12, 2026
- 8-K · FORM 8-KSEC EDGAR · filed May 7, 2026 · fetched Nov 12, 2026
- 8-K · FORM 8-KSEC EDGAR · filed Apr 8, 2026 · fetched Nov 12, 2026
- 8-K · FORM 8-KSEC EDGAR · filed Mar 30, 2026 · fetched Nov 12, 2026